Michael W. Rogers's most recent trade in Akebia Therapeutics Inc. was a trade of 53,600 Stock Option (Right to buy) done . Disclosure was reported to the exchange on June 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Akebia Therapeutics Inc. | Michael W. Rogers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 53,600 | 53,600 | - | - | Stock Option (Right to buy) | |
| Akebia Therapeutics Inc. | Michael W. Rogers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 35,700 | 161,729 (0%) | 0% | 0 | Common Stock | |
| Akebia Therapeutics Inc. | Michael W. Rogers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 45,000 | 45,000 | - | - | Stock Option (Right to buy) | |
| Akebia Therapeutics Inc. | Michael W. Rogers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 30,000 | 126,029 (0%) | 0% | 0 | Common Stock | |
| Akebia Therapeutics Inc. | Michael W. Rogers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 45,000 | 45,000 | - | - | Stock Option (Right to buy) | |
| Akebia Therapeutics Inc. | Michael W. Rogers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 30,000 | 96,029 (0%) | 0% | 0 | Common Stock | |
| Aravive Inc | Michael W. Rogers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2022 | 97,063 | 97,063 | - | - | Stock Option (Right to Buy) | |
| Akebia Therapeutics Inc. | Michael W. Rogers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 20,100 | 20,100 | - | - | Stock Option (Right to buy) | |
| Akebia Therapeutics Inc. | Michael W. Rogers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 13,700 | 66,029 (0%) | 0% | 0 | Common Stock | |
| Aravive Inc | Michael W. Rogers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2021 | 22,812 | 22,812 | - | - | Stock Option | |
| Akebia Therapeutics Inc. | Michael W. Rogers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 20,100 | 20,100 | - | - | Stock Option (Right to buy) | |
| Akebia Therapeutics Inc. | Michael W. Rogers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 13,700 | 52,329 (0%) | 0% | 0 | Common Stock | |
| Aravive Inc | Michael W. Rogers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2020 | 15,024 | 15,024 | - | - | Stock Option | |
| Aravive Inc | Michael W. Rogers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2020 | 14,987 | 14,987 | - | - | Stock Option |